Manufacturer recalling 'subpotent' thyroid tablets, adverse effects reported, FDA says

A manufacturer is recalling thyroid tablets found to be subpotent and with adverse effects, according to the U.S. Food and Drug Administration (FDA).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.